| Dr Delisa Eva Guadarrama, MD | |
|
2821 Michaelangelo Dr Ste 204, Edinburg, TX 78539-1423 | |
| (956) 362-8290 | |
| (956) 362-8295 |
| Full Name | Dr Delisa Eva Guadarrama |
|---|---|
| Gender | Female |
| Speciality | Psychiatry |
| Experience | 13 Years |
| Location | 2821 Michaelangelo Dr Ste 204, Edinburg, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1356637227 | NPI | - | NPPES |
| 3652737-03 | Medicaid | TX | |
| H08MN08301 | Other | TX | BCBS |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | Q7693 (Texas) | Secondary |
| 2084P0804X | Psychiatry & Neurology - Child & Adolescent Psychiatry | Q7693 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Renaissance Medical Foundation | 1153409867 | 86 |
News Archive
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.
› Verified 9 days ago
| Entity Name | Children's Physician Services Of South Texas |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1568658227 PECOS PAC ID: 3678478872 Enrollment ID: O20040324001704 |
News Archive
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.
› Verified 9 days ago
| Entity Name | Nueces County Mental Health & Mental Retardation Community Ctr |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1255357828 PECOS PAC ID: 7618954777 Enrollment ID: O20040707000054 |
News Archive
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.
› Verified 9 days ago
| Entity Name | Coastal Plains Community Mhmr |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1962552109 PECOS PAC ID: 1557337490 Enrollment ID: O20040902000680 |
News Archive
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.
› Verified 9 days ago
| Entity Name | Renaissance Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467633867 PECOS PAC ID: 1153409867 Enrollment ID: O20080422000326 |
News Archive
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.
› Verified 9 days ago
| Entity Name | University Of Texas Rio Grande Valley |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1477960730 PECOS PAC ID: 3577885276 Enrollment ID: O20141209000376 |
News Archive
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Delisa Eva Guadarrama, MD Po Box 749, Pharr, TX 78577-1614 Ph: (956) 362-8290 | Dr Delisa Eva Guadarrama, MD 2821 Michaelangelo Dr Ste 204, Edinburg, TX 78539-1423 Ph: (956) 362-8290 |
News Archive
A team of doctors and scientists from the Champalimaud Clinical Centre in Lisbon, Portugal, and the Netherlands Cancer Institute in Amsterdam, has shown that patients with "low" rectal cancer (that is, very close to the anus) who show no sign of their tumors after a course of radio- and chemotherapy can safely choose to postpone invasive and complication-prone surgical procedures.
Cleveland Clinic has finalized the agenda for the 8th Annual Medical Innovation Summit, which will be held Nov. 1-3 on the Clinic's campus. The Summit draws 1,000 attendees each year, and includes panel discussions with some of the industry's top CEOs and thought leaders.This year's summit will highlight breakthrough technologies for diagnosing and treating obesity and diabetes. Top executives, investors, entrepreneurs, clinicians and technologists will gather to share ideas on how to combat this devastating epidemic.
Nymox Pharmaceutical Corporation announced today its financial results for the second quarter of 2010. Nymox reported a net loss of $1,745,798, or $0.05 per share for the quarter and $3,015,348, or $0.10 per share for the six months ending June 30, 2010, compared to $1,220,152, or $0.04 per share for the quarter and $2,224,411, or $0.07 per share for the six months ending June 30, 2009. Net losses include stock compensation charges for the quarter of $245,245 in 2010 and $248,886 in 2009 and for the six months ending June 30 of $440,465 in 2010 and $558,536 in 2009.
Husband-and-wife doctors at the University of Virginia Cancer Center have been awarded more than $1.8 million from the National Institutes of Health for their effort to improve radiation therapy and breast surgery for patients with early-stage breast cancer.
› Verified 9 days ago
Dr. Mirta Zorrilla, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 4937 S Jackson Rd, Edinburg, TX 78539 Phone: 956-618-2258 Fax: 956-618-2179 | |
Dr. Zuka A Khabbazeh, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 2821 Michaelangelo Dr Ste 306, Edinburg, TX 78539 Phone: 956-362-2440 Fax: 956-362-2448 | |
Dr. Javier Francisco Martinez, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 5115 S Mccoll Rd, Edinburg, TX 78539 Phone: 956-289-7000 Fax: 956-289-7257 | |
Dr. Priti M Manohar, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 3125 Center Pointe Dr, Edinburg, TX 78539 Phone: 956-683-9300 Fax: 956-683-9323 | |
Miguel Angel Petrozzi, M.D., P.A. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1102 W Trenton Rd, Edinburg, TX 78539 Phone: 956-742-1077 | |
Ovidiu Adrian Dulgheru, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 3111 Center Point Dr, Suite B, Edinburg, TX 78539 Phone: 956-686-3220 Fax: 956-630-0074 |